VarCov Co’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-29,403
Closed -$277K – 477
2026
Q2
$277K Sell
29,403
-2,554
-8% -$22.9K 0.11% 288
2026
Q1
$260K Sell
31,957
-7,107
-18% -$64.4K 0.1% 315
2025
Q4
$263K Buy
+39,064
New +$294K 0.1% 325

Other funds holding NVAX

VarCov Co's NVAX Position: Q3 2026 in Review

VarCov Co sold out of Novavax (NVAX) in Q3 2026, closing a stake of 29,403 shares — an estimated $277K sold.

VarCov Co first reported a position in NVAX in Q4 2025 and held it in 3 quarters. The position peaked at $277K in Q2 2026. 262 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • VarCov Co reported no remaining Novavax position as of Q3 2026 after selling out during the quarter.
  • VarCov Co sold 29,403 Novavax shares in Q3 2026, an estimated $277K.
  • VarCov Co first reported a position in Novavax in Q4 2025 and held it in 3 quarters.
  • VarCov Co's Novavax position peaked at $277K in Q2 2026.
  • 262 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.